**Core Concept**
The question tests the understanding of the pathophysiology of iron deficiency anemia and the kinetics of erythropoiesis in response to iron supplementation. **Iron deficiency anemia** is characterized by a decrease in the production of hemoglobin due to inadequate iron availability, leading to a reduction in the number of red blood cells produced in the bone marrow.

**Why the Correct Answer is Right**
The earliest indicator of response after starting iron in a patient with iron deficiency anemia is an **increased reticulocyte count**. This occurs because iron supplementation allows for an increase in the production of new red blood cells (erythropoiesis) in the bone marrow, which are initially released into the bloodstream as reticulocytes. Reticulocytes are immature red blood cells that are larger and more fragile than mature erythrocytes. An increase in reticulocytes is a sign that the bone marrow is responding to iron supplementation by producing more red blood cells.

**Why Each Wrong Option is Incorrect**
**Option B:** Increased hemoglobin is a delayed indicator of response to iron supplementation, as it takes several weeks for the increased production of red blood cells to translate into a measurable increase in hemoglobin levels. Furthermore, hemoglobin levels may initially decrease due to the increased breakdown of red blood cells (hemolysis) as the body clears out the existing iron-deficient red blood cells.
**Option C:** Increased ferritin is a marker of iron stores, not a direct indicator of response to iron supplementation. Ferritin levels may initially decrease as iron is mobilized from stores to meet the increased demand for erythropoiesis, and may not increase until later in the course of treatment.
**Option D:** Increased serum iron is not a reliable indicator of response to iron supplementation, as serum iron levels can fluctuate rapidly due to various factors, including recent meals and inflammation.

**Clinical Pearl / High-Yield Fact**
In children with iron deficiency anemia, a reticulocyte count of 2-3% of total red blood cells is often considered a good indicator of a positive response to iron supplementation. This can be a useful benchmark for clinicians to monitor the effectiveness of treatment.

**✓ Correct Answer: A. Increased reticulocyte count**